Jun 26
Matinas BioPharma faces NYSE notice over equity shortfall; gets until 2027 to comply
Synthesized from 11 sources
Sources (11)
Bias Scale:
LeftCenterRight
Seeking AlphaJun 26, 2026, 10:05 PM
AbbVie's Skyrizi gains pediatric psoriatic disease indicationSeeking AlphaJun 26, 2026, 10:05 PM
Chevron says considering more deals to power U.S. data centersSeeking AlphaJun 26, 2026, 9:58 PM
Lantheus receives Complete Response Letter for LNTH-2501Seeking AlphaJun 26, 2026, 9:48 PM
dLocal is set to join the small-cap Russell 2000 index, eyes liquidity boostSeeking AlphaJun 26, 2026, 9:45 PM
GameStop sees adj. EBITDA above $600M for FY ending Jan. 2027Seeking AlphaJun 26, 2026, 9:38 PM
Matinas BioPharma faces NYSE notice over equity shortfall; gets until 2027 to complyReutersJun 26, 2026, 8:20 PM
S&P 500 ends lower; chips tumble and Moderna ralliesCNBCJun 26, 2026, 7:19 PM
Walmart heir Lukas Walton buys minority stake in the Chicago Bulls and United CenterBloombergJun 26, 2026, 7:07 PM
Musk Cleared by FTC to Buy SpaceX Alumni Firm Mesh in M&A PushCNBCJun 26, 2026, 6:48 PM
CFTC is conducting an investigation into Polymarket, source saysBloombergJun 26, 2026, 5:46 PM
Walmart Billionaire to Buy Minority Stake in NBA’s Chicago BullsComments
No comments yet. Be the first!